Ignite Creation Date:
2025-12-24 @ 8:03 PM
Ignite Modification Date:
2025-12-31 @ 9:09 PM
Study NCT ID:
NCT01133704
Status:
COMPLETED
Last Update Posted:
2010-09-08
First Post:
2010-05-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Immunotherapy With APC8015 (Sipuleucel-T, Provenge) for Asymptomatic, Metastatic, Hormone-Refractory Prostate Cancer
Sponsor:
Dendreon
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D9902A
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None